Phase 4 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women between 18 and 70 years of age.
- People with a confirmed diagnosis of primary invasive breast cancer (a specific type called adenocarcinoma) where medical guidelines recommend chemotherapy either before or after surgery.
- People who have not had any other cancer or received any other chemotherapy.
- People who have not yet received any treatment for their current breast cancer diagnosis.
- People who are generally well enough to carry out everyday activities without significant limitation (confirm with trial site for exact definition).
- People whose blood test results before treatment show healthy levels of blood cells, liver function, and kidney function, meeting specific thresholds set by the trial (confirm with trial site for exact values).
- People who do not have serious problems with the function of their heart, liver, kidneys, or other major organs.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are unwilling or unable to use an acceptable form of contraception during the trial and for up to 8 weeks after the last dose of the study drug.
- People who are currently pregnant or breastfeeding.
- People whose breast cancer has been confirmed to have spread to distant parts of the body.
- People with a confirmed diagnosis of a nerve disease affecting sensation or movement.
- People with a known serious heart or blood vessel condition, a severe other illness, an active infection, or known HIV.
- People who require long-term blood-thinning medication for a heart or blood clot condition.
- People with a history of any other type of cancer.
- People with a known allergy to the study drug or any of its ingredients.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 13777825246
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
complete response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.